{"id":245594,"date":"2011-09-25T15:45:53","date_gmt":"2011-09-25T15:45:53","guid":{"rendered":"http:\/\/www.eugenesis.com\/digipath-is-looking-for-to-hire-sales-representatives\/"},"modified":"2011-09-25T15:45:53","modified_gmt":"2011-09-25T15:45:53","slug":"digipath-is-looking-for-to-hire-sales-representatives","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/digipath-is-looking-for-to-hire-sales-representatives.php","title":{"rendered":"DigiPath is Looking for to Hire Sales Representatives"},"content":{"rendered":"

DigiPath is seeking independent thinking, self motivated, and successful sales resources to lead the adoption of digital pathology worldwide.  With a base salary, customary benefits, and substantial stock grant, this position’s earnings will exceed $250,000 at 100% sales quota attainment. <\/p>

15 positions are available today. DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions.  Recently, DigiPath announced its PathScope, a $24,999 digital pathology slide scanning system. <\/p>

Combining PathScope with PathCloud, a dedicated Tier 1 digital pathology network, DigiPath offers the most affordable, innovative, and reliable solution worldwide. Job requirements include 1) pathology understanding; 2) previous sales success; and 3) motivation to earn money. Locations for consideration are anywhere in USA.<\/p>

See more details at http:\/\/www.digipath.biz<\/a>.  Send your CV for consideration to info@digipath.biz<\/a>.<\/p><\/div>

<\/a> <\/a> <\/a> <\/a> <\/a> <\/a> <\/a> <\/a><\/div>

Source:
http:\/\/feeds.feedburner.com\/DigitalPathologyBlog<\/a><\/p>","protected":false},"excerpt":{"rendered":"

DigiPath is seeking independent thinking, self motivated, and successful sales resources to lead the adoption of digital pathology worldwide.  With a base salary, customary benefits, and substantial stock grant, this position’s earnings will exceed $250,000 at 100% sales quota attainment. 15 … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245594","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245594"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245594"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245594\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}